Antibiotics are prescribed to millions of Americans each year for illnesses ranging from urinary tract infections to pneumonia or bronchitis; however, recent studies have linked fluoroquinolone antibiotics, including Levaquin, Cipro and Avelox, to peripheral neuropathy, a painful and potentially permanent form of nerve damage associated with these popular antibiotics.
Langdon & Emison is reviewing potential lawsuits for users of Levaquin, Cipro or Avelox who have been diagnosed with peripheral neuropathy and may be eligible for financial compensation. For a free case evaluation or to learn more about this litigation, contact our firm at 800-397-4910 or click on the button to the right.
What are fluoroquinolone antibiotics?
Fluoroquinolone antibiotics are the most widely used class of antibiotics in the United States, often prescribed to prevent bacteria from rapidly reproducing and causing infection. This class of antibiotics includes Levaquin, Cipro and Avelox, which can be taken in pill form or by injection.
The medication was first introduced by Johnson & Johnson in 1996.
What is wrong with fluoroquinolone antibiotics?
Levaquin, Cipro and Avelox have been linked to peripheral neuropathy, a condition that damages the nerves in arms, hands, legs or feet and can be responsible for permanent disability and/or chronic pain. Symptoms of peripheral neuropathy include:
- Constant pain.
In 2013, the U.S. Food and Drug Administration issued warnings about the risk of peripheral neuropathy associated with use of fluoroquinolone antibiotics.
Do I have a Levaquin, Cipro or Avelox lawsuit?
If you took Levaquin, Cipro or Avelox before August 15, 2013, and you had immediate onset of peripheral neuropathy, the attorneys at Langdon & Emison will review your case at no cost or obligation to you.
Thousands of lawsuits have been filed across the country alleging Johnson & Johnson failed to provide adequate warnings about the risk of peripheral neuropathy associated with Levaquin, Cipro and Avelox. Pharmaceutical companies are required by law to include label warnings about their products.
Although peripheral neuropathy warnings were added to many of the medications in September 2004, much of the information was false and misleading. The warnings suggested that peripheral neuropathy problems were “rare” and failed to disclose that users may be left with permanent nerve damage.
These issues could have been avoided if stronger warnings were provided to doctors and patients.
Contact Langdon & Emison
Langdon & Emison provides free case evaluations for people who have been diagnosed with peripheral neuropathy or have experienced permanent nerve damage after taking Levaquin, Cipro or Avelox. To learn more, contact our firm at 800-397-4910 or complete an online form.